ArticlePloS one2026
Association between serum platelet level and dermatitis rash: Results from the China Health and Nutrition Survey.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatitis rash (DR), a prevalent inflammatory skin disorder marked by erythema, pruritus, and scaling, poses diagnostic challenges due to overlapping phenotypes with atopic dermatitis and psoriasis. This study examines the relationship between serum platelet (PLT) levels and DR, as the PLT-DR link remains unknown. We used the China Health and Nutrition Survey (CHNS) database, 7,337 participants (172 DR cases, 7,165 controls) were analyzed. Baseline characteristics were compared via weighted chi-square tests. Multifactor regression models and weighted logistic regression assessed the PLT-DR relationship, while restricted cubic splines (RCS) explored nonlinear associations. The impact of age and sex was also evaluated. We found PLT levels significantly reduced DR risk (model 1: odds ratios (OR) = 0.9974 [95% confidence intervals (CI) = 0.9951-0.9998], P = 0.0316; model 2: OR = 0.9976 [95% CI = 0.9953-0.9999], P = 0.0490; model 3: OR = 0.9975 [95% CI = 0.9950-0.9999], P = 0.0398). Covariates such as previous smoking and rural residency were significantly associated with DR. Nonlinear models and risk stratification confirmed these findings, with female sex moderating the PLT-DR relationship. This elucidates that higher PLT levels may independently lower DR risk, suggesting diagnostic potential. PLT thresholds may enhance risk prediction models, aiding early intervention in high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.